DVA
DaVita HealthCare Partners Inc
177.00$
+0.1%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 21.6% | 24.2% | 21.2% | 46.1% | 44.1% | 21.3% | 18.5% | 18.5% | 18.6% | 18.6% | 21.7% | 23.2% | |
| 5.4% | 8.1% | 4.9% | 2.7% | 1.7% | 6.4% | 1.9% | 2.7% | 1.4% | 2.2% | 4.6% | 4.3% | |
| 7.3% | 10.3% | 6.5% | 2.9% | 1.7% | 6.4% | 2.0% | 2.8% | 1.9% | 2.3% | 4.9% | 4.5% | |
| 11.2% | 11.9% | 12.7% | 11.3% | 12.5% | 13.3% | 14.4% | 14.1% | 15.1% | 14.3% | 14.6% | 16.9% | |
| 0.8% | 1.0% | 0.9% | 1.0% | 0.6% | 0.6% | 0.7% | 0.6% | 0.6% | 0.8% | 0.8% | 0.9% | |
| 13.8% | 15.1% | 16.9% | 16.6% | 17.8% | 20.1% | 20.7% | 20.3% | 19.2% | 33.0% | 30.9% | 29.8% | |
| 52.5% | 50.3% | 50.2% | 34.9% | 35.9% | 39.2% | 40.7% | 41.2% | 41.8% | 42.1% | 42.7% | 43.2% | |
| 10.9% | 9.1% | 8.2% | 0.6% | 0.5% | 0.8% | 1.0% | 1.0% | 1.1% | 1.2% | 1.1% | 1.3% | |
| 65.5% | 67.8% | 68.9% | 68.9% | 73.7% | 79.8% | 82.9% | 86.2% | 86.9% | 83.8% | 87.9% | 93.4% | |
| 11.6% | 12.8% | 14.4% | 16.0% | 25.6% | 13.7% | 14.6% | 14.0% | 15.5% | 15.6% | 17.2% | 18.0% | |
| 0.7% | 0.7% | 0.9% | 0.9% | 10.1% | 2.7% | 3.2% | 3.3% | 3.7% | 3.1% | 3.9% | 3.1% | |
| 2.5% | 2.7% | 2.8% | 2.7% | 2.4% | 2.3% | 2.6% | 2.3% | 2.8% | 3.0% | 3.2% | 4.0% | |
| 46.7% | 48.7% | 47.7% | 48.3% | 42.8% | 46.1% | 46.6% | 51.0% | 51.3% | 48.9% | 53.1% | 58.1% | |
| 34.5% | 32.2% | 31.1% | 31.1% | 26.3% | 20.2% | 17.1% | 13.8% | 13.1% | 16.2% | 12.1% | 6.6% | |
| 22.8% | 23.6% | 19.8% | 19.2% | 14.4% | 8.3% | 5.0% | 2.1% | 1.0% | 3.5% | 8.9% | -1.9% | |
| 1.2% | 1.2% | 1.1% | 1.0% | 0.9% | 0.9% | 0.7% | 0.6% | 0.6% | 0.6% | 0.5% | 0.5% |
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.